Health Insurance Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Centre Hospitalier de l'Universite de Charles Nicolle, Rouen, France
Esophageal cancer patients with metal stents developed complications more frequently before chemoradiotherapy
August 13th, 2006
Esophageal cancer patients with self-expanding metal stents developed life-threatening complications more frequently prior to chemoradiotherapy. According to recent research published in the journal Alimentary Pharmacology & Therapeutics, "Self-expanding metal stents are used routinely to palliate dysphagia due to oesophageal cancer. [The study's aim was] to compare the frequency of life-threatening complications after self-expanding metal stent insertion, depending on whether patients received prior chemoradiotherapy or no treatment." "During 7 years, 116 consecutive patients were treated at a single centre in a palliative intent by insertion...
Source: Health Insurance Law Weekly (2006-08-13)
|
